Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03062696 · ClinicalTrials.gov registry record · NA
A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder (CBT-RD)
A NA study of Rumination Disorder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT03062696 is a NA study of Rumination Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03062696, a NA study of Rumination Disorder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary aim of this study is to pilot cognitive behavioral therapy (CBT-RD) for 10 individuals ages 10 and older who have rumination disorder
Conditions Studied
Interventions
- BEHAVIORAL CBT-RD
Study Locations (2)
Massachusetts
- Ani Keshishian - Boston
Pennsylvania
- Drexel University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-05-19 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03062696
The ClinicalTrials.gov registry entry for NCT03062696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rumination Disorder appearing as the primary indexed condition, and to 1 intervention - of which CBT-RD is the first listed.
NCT03062696 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03062696 about?
NCT03062696 is a clinical study titled "A Pilot Study of Cognitive-Behavioral Therapy for Rumination Disorder (CBT-RD)". The primary aim of this study is to pilot cognitive behavioral therapy (CBT-RD) for 10 individuals ages 10 and older who have rumination disorder
What is the current status of trial NCT03062696?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-05-19. Estimated completion is 2019-02-01.
What conditions does trial NCT03062696 study?
This clinical trial studies the following conditions: Rumination Disorder.
What interventions are being tested in trial NCT03062696?
The interventions under investigation include: CBT-RD (BEHAVIORAL).
Who is sponsoring clinical trial NCT03062696?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03062696 being conducted?
This trial has 2 study locations across Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.